Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
10.3390/cancers12030685 Cancers
Certificate of Analysis with lot number, HPLC chromatogram, mass-spec confirmation, and endotoxin reading
Recent Phase 3 data showed average weight reduction exceeding 28% in some participant groups after extended treatment periods
Western blot analysis Proteins were extracted from tissues and cells, and then protein concentrations were quantified using a Bis-creatine (BCA) kit
Concomitant antidiabetic therapies were frequently reported, with metformin being the most frequently reported concomitant medication (n = 1,879), followed by pioglitazone (n = 478), insulin glargine (n = 474), glipizide (n = 467), and glimepiride (n = 345) (Figure S1)
They received 12 mg once weekly retatrutide injections subcutaneously for 12 weeks
US$ 20.53
US$ 27.51
US$ 21.70
US$ 28.57
US$ 25.09
